Roivant Sciences News

Roivant Sciences' (NASDAQ:ROIV) Performance Raises Some Questions

Even though Roivant Sciences Ltd. (NASDAQ:ROIV) posted strong earnings recently, the stock hasn't reacted in a large way. We decided to have a deeper look, and we believe that investors might be worr

Simply Wall StJun 6 07:41 ET

Buy Rating Justified by Roivant Sciences' Growth Prospects and Strategic Pipeline Expansion

TipRanksMay 31 10:05 ET

The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts

6 analysts have shared their evaluations of Roivant Sciences (NASDAQ:ROIV) during the recent three months, expressing a mix of bullish and bearish perspectives.Summarizing their recent assessments, th

BenzingaMay 31 10:00 ET

Piper Sandler Keeps Their Buy Rating on Roivant Sciences (ROIV)

TipRanksMay 31 07:05 ET

Express News | HC Wainwright & Co. Reiterates Buy on Roivant Sciences, Maintains $18 Price Target

BenzingaMay 31 06:38 ET

Roivant Sciences Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 71.43% HC Wainwright & Co. $18 → $18 Reiterates Buy → Buy 04/22/2024 71.43% HC Wainwright & Co.

BenzingaMay 31 06:37 ET

Express News | Roivant Sciences Ltd : Guggenheim Raises Target Price to $18 From $16

ReutersMay 31 06:32 ET

Analysts Conflicted on These Healthcare Names: Canopy Growth (CGC), Ultragenyx Pharmaceutical (RARE) and Roivant Sciences (ROIV)

TipRanksMay 30 23:10 ET

Risinger Recommends 'Buy' for Roivant Sciences With Optimistic Brepocitinib Revenue Forecast and Increased Price Target

TipRanksMay 30 21:55 ET

10-K: Annual report

SEC announcementMay 30 16:49 ET · Announcements

Daily short sale tracking: American Airlines's short volume increased by 22 million, with a short sale ratio of 17%

American Airlines(AAL.US) ranked top of the list had the largest change in short volume (22.1 million shares), and the short volume ratio of Levi Strauss & Co.(LEVI.US) reached 48.04%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.

moomoo NewsMay 30 09:00 ET

Express News | Roivant Sciences Ltd: Novaquest Agreement Amendment Provides for Elimination of Fixed Quarterly Payments Totaling $176.3 Mln

ReutersMay 30 07:49 ET

Express News | Roivant Sciences Ltd: On May 24, 2024, Dermavant Entered Into an Amendment to Novaquest Agreement

ReutersMay 30 07:49 ET

Roivant Sciences' Fiscal Q4 Net Loss Widens, Revenue Rises

Roivant Sciences (ROIV) reported a fiscal Q4 net loss Thursday of $0.19 per diluted share, widening from a loss of $0.05 a year earlier. Analysts polled by Capital IQ expected a loss of $0.30. Net rev

MT NewswiresMay 30 07:31 ET

Express News | Roivant Sciences Ltd - in May 2024, Roivant Renegotiated Dermavant's Debt Obligations, Reducing Potential Cash Payments Due by Over $300M in Aggregate

ReutersMay 30 07:07 ET

Express News | Roivant Sciences Ltd - Consolidated Cash, Cash Equivalents and Restricted Cash of $6.6B at March 31, 2024, Supporting Cash Runway Into Profitability

ReutersMay 30 07:05 ET

Roivant Sciences 4Q Rev $28.9M >ROIV

Roivant Sciences 4Q Rev $28.9M >ROIV

Dow JonesMay 30 07:03 ET

Express News | Roivant Sciences Q4 2024 GAAP EPS $(0.19) Beats $(0.32) Estimate, Sales $28.930M Miss $32.101M Estimate

BenzingaMay 30 07:02 ET

Futures Decline Pre-Bell as Traders Await Key Economic Reports; Asia Down, Europe Rises

US equity markets were pointing lower in Thursday's premarket activity, as investors await key economic data, including the second estimate of the first-quarter gross domestic product report at 8:30 a

MT NewswiresMay 30 07:00 ET

Express News | Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update

ReutersMay 30 07:00 ET